Growth Metrics

Cresco Labs (CRLBF) Non-Current Deferred Tax Liability (2019 - 2026)

Cresco Labs filings provide 8 years of Non-Current Deferred Tax Liability readings, the most recent being $66.1 million for Q1 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 8.87% to $66.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $66.1 million, a 8.87% decrease, with the full-year FY2025 number at $71.6 million, changed N/A from a year prior.
  • Non-Current Deferred Tax Liability hit $66.1 million in Q1 2026 for Cresco Labs, down from $71.6 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $89.4 million in Q4 2023 to a low of $40.9 million in Q3 2024.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $72.6 million (2025), compared with a mean of $67.7 million.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: surged 93.39% in 2022 and later crashed 44.9% in 2024.
  • Cresco Labs' Non-Current Deferred Tax Liability stood at $75.1 million in 2022, then grew by 18.99% to $89.4 million in 2023, then plummeted by 54.27% to $40.9 million in 2024, then soared by 75.12% to $71.6 million in 2025, then fell by 7.66% to $66.1 million in 2026.
  • The last three reported values for Non-Current Deferred Tax Liability were $66.1 million (Q1 2026), $71.6 million (Q4 2025), and $72.6 million (Q3 2025) per Business Quant data.